- Home
- PMCB vs ABTS Comparison
PMCB vs ABTS Comparison
Compare PMCB & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- ABTS
- Stock Information
- Founded
- PMCB 1996
- ABTS 2010
- Country
- PMCB United States
- ABTS Hong Kong
- Employees
- PMCB N/A
- ABTS N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- ABTS Computer Software: Programming Data Processing
- Sector
- PMCB Health Care
- ABTS Technology
- Exchange
- PMCB Nasdaq
- ABTS Nasdaq
- Market Cap
- PMCB 7.3M
- ABTS 9.8M
- IPO Year
- PMCB N/A
- ABTS N/A
- Fundamental
- Price
- PMCB $1.14
- ABTS $5.09
- Analyst Decision
- PMCB
- ABTS
- Analyst Count
- PMCB 0
- ABTS 0
- Target Price
- PMCB N/A
- ABTS N/A
- AVG Volume (30 Days)
- PMCB 11.9K
- ABTS 50.8K
- Earning Date
- PMCB 08-12-2025
- ABTS 08-16-2025
- Dividend Yield
- PMCB N/A
- ABTS N/A
- EPS Growth
- PMCB N/A
- ABTS N/A
- EPS
- PMCB 1.29
- ABTS N/A
- Revenue
- PMCB N/A
- ABTS $6,711,225.00
- Revenue This Year
- PMCB N/A
- ABTS N/A
- Revenue Next Year
- PMCB N/A
- ABTS N/A
- P/E Ratio
- PMCB $0.88
- ABTS N/A
- Revenue Growth
- PMCB N/A
- ABTS 299.11
- 52 Week Low
- PMCB $1.00
- ABTS $1.35
- 52 Week High
- PMCB $2.42
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- PMCB 59.67
- ABTS 64.83
- Support Level
- PMCB $1.00
- ABTS $3.53
- Resistance Level
- PMCB $1.07
- ABTS $4.28
- Average True Range (ATR)
- PMCB 0.05
- ABTS 0.53
- MACD
- PMCB 0.01
- ABTS 0.03
- Stochastic Oscillator
- PMCB 93.33
- ABTS 87.12
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.